entertainment -WSS

entertainment

author：entertainment 2025-10-01 21:36:44 - browse：2515

Sammy Kimball for STAT

Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should lawyers be allowed to use thesauruses?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain Merck’s lawsuit against the federal government and why the company believes drug pricing negotiation is “tantamount to extortion.” We also discuss the health effects of Canadian wildfires, the highlights of the year’s biggest cancer research conference, and what could be a watershed moment in the treatment of Alzheimer’s.

For more on what we cover, here’s the latest on Merck; here’s more from ASCO; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Padmanee Sharma of MD Anderson at center of lawsuit over credit

focus

WSS

AI gets buy

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Bernie brings in new pharma CEOs to talk drug prices

Patient advocates debate FDA's accelerated approval process

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

entertainment

entertainment

leisure time

Medical leaders decry Supreme Court decision on affirmative action

Abortion pill Supreme Court ruling could impact entire drug industry

Supreme Court strikes down use of affirmative action

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Medicare details structure of new drug price negotiation program

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

BioMarin wins approval for gene therapy to treat hemophilia A

Roche subsidiary Foundation Medicine opens new headquarters

Hepatitis C has a cure — but many Americans still lack access to it

Primary care physicians play key roles in Alzheimer's management

explore

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Bernie brings in new pharma CEOs to talk drug prices

Adopting new red light myopia treatments may be short

Johnson & Johnson sued for allegedly overpaying for workers' drugs

focus

entertainment

focus

hotspot